Abstract
Ceftriaxone (RO 13-9904) has only recently been introduced in Benghazi and many parts of the word. We determined itsin vitro antibacterial activity against the primary aetiological agents of childhood meningitis in Benghazi, that included eighteen (23.3%) strains ofH. influenzas, 17 (22.1%) ofStr. pneumoniae and 1 (1.3%) ofN. meningitidis isolated from 77 cases of acute purulent meningitis above the age of neonatal period. All strains ofH. influenzae. Str. pneumoniae andN. meningitidis were sensitive to ceftriaxone and showed wide zones of inhibition by the disc diffusion technique of Kirby-Bauer. Ampicillin and chloramphenicol resistance was observed forH. influenzae (23% and 11% respectively), andStr. pneumoniae (12% and 0% respectively), in addition, 18% of strains ofStr. pneumoniae showed resistance to penicillin. The broad spectrum activity of ceftriaxone has been confirmed for our locality and this finding, together with its exceptionally long half-life, excellent penetration into the C.S.F. and ease of administration (single daily dose) warrants it as the drug of choice in empherical treatment of cases of acute bacterial meningitis in children in Benghazi and in cases where resistance to ampicillin and chloramphenicol are found on subsequent testing.
Similar content being viewed by others
References
Mc Gee Z, Kaiser A. Acute meningitis; In: Mandell DB ed.Infectious Diseases. Wiley Medical Publication, 1985; 560–564.
Anon. The choice of antimicrobial drugs.The Medical Letter on drugs and therapeutics 1988; 30 (issues 162); 33–34.
Sande M. A guide to empiric theray for Acute Bacterial Meningitis.Modern Medicine 1989; 57: 100–103.
Stutman H, Marks MI. Bacterial Meningitis in Children ; Diagnosis and therapyClin Pediatr 1987; 26: 431–438.
Peltola H, Anttila M, Renkonen OA. Randomised comparison of chloramphenicol, ampicillin, cefotaxime, ceftraxone for Childhood Bacterial Meningitis.Lancet 1989; 1: 1281–1287.
Word B, Klein J. Current therapy of bacterial sepsis and meningitis in infants and children. A poll of directors of programs in pediatric infectious diseases.Ped Infect Dis J 1988; 7: 267–270.
Istre GR, Hamphreys JT, Albercht KD.et al. Chloramphenicol and penicillin resistance to pneumococci isolated from blood and CSF a prevalence study in metropolitan Denver.J Clin Microbiol 1983; 17: 472–475.
Appelbaum PC. World wise development of antibiotic resistance in pneumococci.Eur J Clin Microbiol 1987; 6: 367–377.
Gustafson TL, Kelley RA, Hutcheson RH, Schaffner W, Sell SH. Statewide survey of antimicrobial susceptibilities ofH. influenzae producing invasive disease in Tennessee.Pediatr Infect Dis 1983; 2: 119–122.
Uchiyama N, Green GR, Kitts DB, Thrupp LD. Meningitis due toHaemophilus influenzae type b resistant to ampicillin and chloramphenicol.J Pediatr 1980; 97: 421–424.
Botha P. Penicillin resistantN. meningitidis in Southern Africa.Lancet 1988; 1: 9.
Sprott MS, Kearns AM, Field JM. Penicillin insensitiveN. meningitidis Lancet 1988; 1: 1167.
Hall MJ, Westmacott JD, Wongkain P. Comparative invitro activity and mode of action of ceftriaxone. A new highly potent cephalosporinJ Antimicrob Chemother 1981; 8: 193–203.
Fass RJ. Comparative in vitro activities of third generation cephalosporins.Arch Inter Med 1983; 143: 1743–1745.
Chadwick EG, Yoger R, Shulman ST, Weinfield RE, Patel IH. Single-dose ceftriaxone pharmacokinetics in pediatric patients in central nervous system infections.J Pediatr 1983; 102: 134–137.
Steele RW, Eyre CB, Bradsker RW, Weinfield RE, Patel IH, Spicehandler J. Pharmacokinetics of ceftriaxone inpediatric patients with meningitis.Antimicrob agents Chemother 1983; 23: 191–194.
Collee JG, Dugwid JP, Fraser AGet al. Mackie and McCartney PracticalMedical Microbiology, 13th ed. Edinburgh, Churchill Livingstone, 1989.
Stoke EJ, Ridgway CL.Clinical Bacteriology 5th ed. London, Edward Arnold, 1987.
Wafa M, Hassan N, Akhtar MJet al. Acute Bacterial Meningitis in Neonates and Infants in Benghazi.Garyounis Med J 1980; 3: 55–59.
Deivanayagam IV. Ashok TP, Nedunnchelian Ket al. Bacterial Meningitis: Diagnosis by Latex Agglutination Test and clinical features.Indian Pediatr 1993; 30: 495–499.
Al-Jurayyan NAM, Al-Mazyad AS, Al-Nasser NWSel al Childhood Bacterial Meningitis in AL-Baha Province, Saudi Arabia.J Trop Med Hyg 1992; 95: 180–185.
Donald PR, Burger PJ, Becker WB. Pediatric Meningitis in Western Cape: 3 year Hospital Based prospective study.South Afri Med J 1986; 70: 391–395.
Goldacre MJ. Acute Bacterial Meningitis in Childhood. Incidence and Mortality.Lancet 1991; i: 505–511.
Greenwood BM. The epidemiology of Acute Bacterial Meningitis in tropical Africa. In:Bacterial Meningitis London, Academic Press 1987; 61–87.
Nabi G, Khan TA, Ray ABet al Bacterial Meningitis in Children.Saudi Med J 1992; 13: 348–351.
Frosser J. Chloramphenicol treatment of Childhood Bacterial Meningitis (letter).Lancet 1989; ii: 161.
Campos J, Tornel SG, Gairi JMet al. Multiply resistantH. influenzae type b causing meningits. Comparative clinical, laboratory study.J Paediatr 1986; 108: 897–902.
Elman W, Konemann EW, Janda WMet al. Colour Atlas and Textbook of Diagnostic Microbiology. 4th ed. Philadelphia, JB Lippincott Company, 1992; 284.
Mendelman PM, Chaffin DO, Claceen Cet al. Failure to detect ampicillin resistance, non-beta-lactamase producingH. influenzae by a standard disc susceptibility testing.Antimicrob agents Chemother 1986; 30: 274–280.
Ward J. Antibiotic resistantStreptococcus pneumoniae. Clinical and epidemiologic aspectsRev Infect Dis 1981; 3: 254–266.
Wells TG, Trang JM, Brown Alet al. Cefotaxime therapy of Bacterial Meningitis in Children.J Antimicrobial Chemother 1984; 14 (suppl. B): 181–189.
Odio CM, Faingezicht I, Salas JLet al. Cefotaxime vs conventional therapy for the treatment of Bacterial Meningitis of Infants and Children.Pediatr Infect Dis 1986; 5: 402–407.
Steele RW, Bradsher RW. Comparison of ceftriaxone with standard therapy for the treatment of Bacterial meningitis.J Pediatr 1983; 103: 138–144.
Congeni BL. Comparison of ceftriaxone and traditional therapy for the treatment of Bacterial Meningitis.Antimicrob agents Chemother 1984; 13: 143–151.
Barrow WJ, Miller MA, Brady MT, Powell OA. Prospective comparative trail of ceftriaxone to conventional therapy for treatment of Bacterial Meningitis in Children.Pedia Infect Dis 1985; 4: 362–368.
Tanner DJ, Cost containment of reconstituted parenteral antibiotics: Personnel and supply costs associated with preparation, dispensing and administration.Rev Infect Dis 1984; 6: 5929–5937.
Powell KR, Manhorter SS. Out-patient treatment of serious infections in infants and children with ceftriaxone.J Pediatr 1987; 110: 898–901.
Sande MA. Antibiotic therapy of Bacterial Meningitis. Lessons we have learned.Am J Med 1981; 71: 507–510.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rao, B.N., Kashbur, I.M., Shembesh, N.M. et al. In vitro antibiotic sensitivity pattern of common bacterial isolates from cases of acute bacterial meningitis with special reference to ceftriaxone. Indian J Pediatr 64, 849–854 (1997). https://doi.org/10.1007/BF02725510
Issue Date:
DOI: https://doi.org/10.1007/BF02725510